Title
The RAB39B p.G192R mutation causes X-linked dominant Parkinson's disease
Date Issued
24 September 2015
Access level
open access
Resource Type
journal article
Author(s)
Mata I.F.
Jang Y.
Kim C.H.
Hanna D.S.
Dorschner M.O.
Samii A.
Agarwal P.
Roberts J.W.
Klepitskaya O.
Shprecher D.R.
Chung K.A.
Factor S.A.
Espay A.J.
Revilla F.J.
Higgins D.S.
Litvan I.
Leverenz J.B.
Yearout D.
Martinez E.
Thompson T.R.
Cholerton B.A.
Hu S.C.
Edwards K.L.
Kim K.S.
Zabetian C.P.
Publisher(s)
BioMed Central Ltd.
Abstract
Objective: To identify the causal gene in a multi-incident U.S. kindred with Parkinson's disease (PD). Methods: We characterized a family with a classical PD phenotype in which 7 individuals (5 males and 2 females) were affected with a mean age at onset of 46.1 years (range, 29-57 years). We performed whole exome sequencing on 4 affected and 1 unaffected family members. Sanger-sequencing was then used to verify and genotype all candidate variants in the remainder of the pedigree. Cultured cells transfected with wild-type or mutant constructs were used to characterize proteins of interest. Results: We identified a missense mutation (c.574G > A; p.G192R) in the RAB39B gene that closely segregated with disease and exhibited X-linked dominant inheritance with reduced penetrance in females. The mutation occurred in a highly conserved amino acid residue and was not observed among 87,725 X chromosomes in the Exome Aggregation Consortium dataset. Sequencing of the RAB39B coding region in 587 familial PD cases yielded two additional mutations (c.428C > G [p.A143G] and c.624-626delGAG [p.R209del]) that were predicted to be deleterious in silico but occurred in families that were not sufficiently informative to assess segregation with disease. Experiments in PC12 and SK-N-BE(2)C cells demonstrated that p.G192R resulted in mislocalization of the mutant protein, possibly by altering the structure of the hypervariable C-terminal domain which mediates intracellular targeting. Conclusions: Our findings implicate RAB39B, an essential regulator of vesicular-trafficking, in clinically typical PD. Further characterization of normal and aberrant RAB39B function might elucidate important mechanisms underlying neurodegeneration in PD and related disorders.
Volume
10
Issue
1
Language
English
OCDE Knowledge area
Neurología clínica Genética, Herencia
Scopus EID
2-s2.0-84958520687
PubMed ID
Source
Molecular Neurodegeneration
ISSN of the container
17501326
Sponsor(s)
This work was supported by grants from the National Institutes of Health (P50 NS062684, R01 NS065070, R01 NS084869) and the Department of Veterans Affairs (1I01BX000531), and by a gift from the Dolsen Foundation. We thanks all of the individuals who participated in the study and Drs. Jennifer Witt and Rosalind Chuang for assistance with patient recruitment.
Sources of information: Directorio de Producción Científica Scopus